Holowesko Partners Ltd. Astrazeneca PLC Transaction History

Holowesko Partners Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $1.97 Million - $2.11 Million	-57,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $48.4 Million - $53.8 Million	-1,469,000 Reduced 96.26%	57,000 $1.99 Million
Q4 2017 Feb 12, 2018	SELL	$32.09 - $34.78 $11.9 Million - $12.9 Million	-372,000 Reduced 19.6%	1,526,000 $53 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $55 Million - $64.5 Million	1,898,000	1,898,000 $64.3 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Holowesko Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Holowesko Partners Ltd. with notifications on news.